Isoflavonen goed tegen botontkalking.*

Researchers from Great Britain performed the double-blinded, randomized, placebo-controlled study on isoflavone phytoestrogen therapy. 205 women between the ages of 49 to 65 years old were enrolled in the study, which lasted for one year. Half of the group was treated with a red clover-derived isoflavone supplement providing over 40 mg of various isoflavones, while the other half was treated with a placebo. At the end of the one-year study, loss of lumbar spine bone mineral content and bone mineral density was significantly lower in the women who were treated with the isoflavone supplement, compared to those taking placebo. In addition, bone formation markers were significantly increased in the isoflavone-treated group. The authors concluded that although there was attenuation (reduction) of bone loss, the data suggested that isoflavones have a potentially protective effect on the lumbar spine in women. (2004 edition of the American Journal of Clinical Nutrition)  

    Printen